Abstract:Background Cutaneous epidermal nevi are genotypically diverse mosaic disorders. Pathogenic hotspot variants in HRAS , KRAS , and less frequently , NRAS and BRAF may cause isolated keratinocytic epidermal nevi and sebaceous nevi or several different syndromes when associated with extracutaneous anomalies. Therefore, some authors suggest the concept of mosaic RASopathies to group these different disorders. Methods In this paper, we describe three new cases of syndromic epidermal nevi caused by mosaic HRAS variants: one associating an extensive keratinocytic epidermal nevus with hypomastia, another with extensive mucosal involvement and a third combining a small sebaceous nevus with seizures and intellectual deficiency. Moreover, we performed extensive literature of all cases of syndromic epidermal nevi and related disorders with confirmed pathogenic postzygotic variants in HRAS, KRAS, NRAS or BRAF . Results Most patients presented with bone, ophthalmological or neurological anomalies. Rhabdomyosarcoma, urothelial cell carcinoma and pubertas praecox are also repeatedly reported. KRAS pathogenic variants are involved in 50% of the cases, especially in sebaceous nevi, oculoectodermal syndrome and encephalocraniocutaneous lipomatosis. They are frequently associated with eye and brain anomalies. Pathogenic variants in HRAS are rather present in syndromic keratinocytic epidermal nevi and phacomatosis pigmentokeratotica. Conclusion This review delineates genotype/phenotype correlations of syndromic epidermal nevi with somatic RAS and BRAF pathogenic variants and may help improve their follow-up.

Hue and saturation shifts from spatially induced blackness.

The first case of Chinese phacomatosis pigmentokeratotica diagnosed by a missense HRAS mosaicism

A Case of Ichthyosis Follicularis, Atrichia and Photophobia Syndrome Caused by a Novel Mutation in the MBTPS2 Gene

Estrogens and human cardiovascular physiology.

Comparison of three radioligands, selenium-75, lodine-125, and tritium, in the radioimmunoassay of methotrexate.

A Novel Mutation Within the 2B Rod Domain of Keratin 9 in a Chinese Pedigree with Epidermolytic Palmoplantar Keratoderma Combined with Knuckle Pads and Camptodactyly

Phacomatosis pigmentokeratotica: Exploring extracutaneous comorbidities and topical therapy

KRT9 Gene Mutation As a Reliable Indicator in the Prenatal Molecular Diagnosis of Epidermolytic Palmoplantar Keratoderma.

Unilateral Focal Palmoplantar Keratoderma Associated with a Postzygotic Variant in PIK3CA and Activation of the PI3K/AKT/mTOR Pathway.

Keratin K6c mutations cause focal palmoplantar keratoderma

[Pathological Features and Gene Mutation Analysis in Two Pedigrees of Diffuse Palmoplantar Keratoderma].

Pigmented trichoblastoma developed in a sebaceous nevus: HRAS mutation as a common molecular driver

Comparison of body surface temperature measurement and conventional methods for measuring temperature in the mouse.

Cutaneous Skeletal Hypophosphatemia Syndrome in Association with a Mosaic HRAS Mutation

Mosaic RASopathies concept: different skin lesions, same systemic manifestations?

A spectrum of mutations in keratins K6a, K16 and K17 causing pachyonychia congenita

Extracellular hydrolase activity of the cells of the oral bacterium Streptococcus mutans isolated from man and grown on glucose or xylitol.

Expansion of the phenotypic spectrum and description of molecular findings in a cohort of patients with oculocutaneous mosaic RASopathies

Mutations in desmoglein 1 cause diverse inherited palmoplantar keratoderma phenotypes: implications for genetic screening

Biomolecule Mediating Synthesis Of Inorganic Nanoparticles And Their Applications

Influenza NS1 interacts with p53 and alters its binding to p53‐responsive genes, in a promoter‐dependent manner